Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-28

Clinical Trial Update: TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS [NA]

View source ↗

Summary

Clinical trial update indicating that transcutaneous auricular vagus nerve stimulation (TaVNS) shows symptom improvements in moderate-to-severe chronic prostati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: Jiani Wu | Conditions: Chronic Prostatitis | NA | Status: RECRUITING